South Korea’s ABL Bio Corp (KS: 298380) on Friday revealed that it has entered into a clinical trial collaboration and supply ...

AstraZeneca's Airsupra (albuterol/budesonide) met the primary endpoint in the Phase III BATURA trial, significantly reducing ...

AstraZeneca has entered into an exclusive license agreement with China’s CSPC Pharmaceutical to advance the development of an ...

BeiGene has launched Tevimbra (tislelizumab) in the USA for treating adults with esophageal squamous cell carcinoma (ESCC) ...

Kezar Life Sciences has paused its Phase IIb PALIZADE trial for zetomipzomib in lupus nephritis after four patient deaths, ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) revealed it is discontinuing the Phase II field study (NCT05201794) ...

US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country ...

India's new Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is a significant step ...

The Irish Healthcare Association (IPHA), the representative body for the research-based biopharmaceutical industry in ...

ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of ...

Important regulatory news last week included French pharma major Sanofi gaining approval from the US Food and Drug ...

Mpox has proven to be a major public threat since its resurgence globally during the COVID years. On August 14, the World ...